Skip to main content

Table 3 Frequency of CSCs markers positive cases

From: Immunohistochemical analysis of cancer stem cell markers in pancreatic adenocarcinoma patients after neoadjuvant chemoradiotherapy

 

NACRT(n = 17)

Non-NACRT(n = 11)

P-value

EpCAM(+)

58.8%

45.5%

0.700

CD24(+)

35.3%

36.4%

1.000

CD44(+)

82.4%

18.2%

0.00148

CD133(+)

29.4%

81.8%

0.0183

CXCR4(+)

47.1%

27.2%

0.435

ALDH1(+)

64.7%

18.2%

0.0237

  1. Fisher’s exact test.
  2. The bold value indicates a statistically significant result.
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us